Extracorporeal shock wave lithotripsy of impacted radiolucent stone at the right pyeloureteric junction and oral dissolution therapy in a patient with transplanted liver: a case report.
Extracorporeal shock wave lithotripsy (ESWL) is a safe, effective method to treat urinary lithiasis. The success rate in ESWL depends on stone location, size, number, and fragility as well as calceal anatomy and patency of the urinary tract. An association of calcineurin inhibitors and uric acid urolithiasis has been reported in renal allograft recipients, but the mechanism remains unknown. Herein we have reported the case of 68-year-old male patient who developed cryptogenic cirrhosis and underwent liver transplantation. Seven years after transplantation, the patient was admitted to the hospital with right renal colic. An 8.9-mm radiolucent stone at the pyeloureteric junction was associated with moderate consecutive hydronephrosis. The second stone was located in a lower renal calyx. After a failed attempt at retrograde ureteral stenting, we performed a percutaneous nephrostomy. Antegrade pyelography with following ESWL treatment resulted in disintegration of the obstructive stone at the pyeloureteric junction. Afterward, we performed antegrade placement of a double-J stent. Residual stones in the lower renal calyx were successfully treated with a 3-month course of oral intake of a dissolution agent-potassium sodium hydrogen citrate. In this case, we have discussed ESWL and oral dissolution therapy of radiolucent stones in a hydronephrotic right kidney, which resulted in stone-free disease after 3 months of combined therapy. There was neither clinical nor biochemical damage to the transplanted liver.
Mokos
I
I
Department of Urology, University, Hospital Center Zagreb, Zagreb, Croatia. ivica.mokos@zg.htnet.hr
Pasini
J
J
Hrstić
I
I
Stern-Padovan
R
R
Cacic
Z
Z
Knezevic
N
N
D000368:Aged; D002951:Citrates / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D007669:Kidney Calculi / Q000188:drug therapy* / Q000628:therapy*; D008096:Lithotripsy; D008103:Liver Cirrhosis / Q000601:surgery; D016031:Liver Transplantation; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy / Q000628:therapy; D011188:Potassium / Q000627:therapeutic use; D012964:Sodium / Q000627:therapeutic use; D014513:Ureter
D002951:Citrates; D012964:Sodium; D011188:Potassium